In summary the PacBio sequencing assay can be applied to detect BCR-ABL1 resistance mutations in both diagnostic and follow-up CML patient samples using a simple protocol applicable to routine diagnosis. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.